Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma

24 Jun 2021

Abstract excerpt

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer, with high incidence and mortality. To improve the curative effect and prolong the survival of patients, it is necessary to find new biomarkers to accurately predict the prognosis of patients and explore new strategy to treat high-risk LUAD. METHODS: A comprehensive genome-wide profiling analysis was conducted using a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to Kruppel-like factors research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34249701
DOI: 10.3389/fonc.2021.665276

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung AdenocarcinomaPMID 34249701Read ↗

The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformaticsSemantic proximity Read ↗

Identification of a novel m5C/m6A-related gene signature for predicting prognosis and immunotherapy efficacy in lung adenocarcinomaSemantic proximity Read ↗

A 5-mRNA-Based Prognostic Signature of Survival in Lung AdenocarcinomaSemantic proximity Read ↗

Identification of an eight-gene prognostic signature for lung adenocarcinomaSemantic proximity Read ↗

Systematical identifications of prognostic meaningful lung adenocarcinoma subtypes and the underlying mutational and expressional characters.Semantic proximity Read ↗

Integration of osimertinib-targeted EGFR gene-associated differential gene expression in constructing a prognostic model for lung adenocarcinomaSemantic proximity Read ↗

Drug resistance related genes in lung adenocarcinoma predict patient prognosis and influence the tumor microenvironmentSemantic proximity Read ↗

Establishment of a Gene Signature to Predict Prognosis for Patients with Lung AdenocarcinomaSemantic proximity Read ↗

Prognostic Signature for Lung Adenocarcinoma Patients Based on Cell-Cycle-Related GenesSemantic proximity Read ↗

BIRC5 as a Potential Biomarker and Therapeutic Target for Lung Adenocarcinoma: A Comprehensive Bioinformatics AnalysisSemantic proximity Read ↗

Identification of Key Genes and Clinical Feature Analyses of Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinoma.Semantic proximity Read ↗

Identification of hub-methylated differentially expressed genes in lung adenocarcinoma and immunotherapy resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.